Breau AP[au] - Search Results

Year	Number of Results
1979	1
1984	2
1985	1
1991	1
1993	2
1996	1
1999	2
2000	4
2002	1
2003	9
2004	2
2005	1
2006	1
2012	1
2013	1
2022	0

1

Integrated histopathological and urinary metabonomic investigation of the pathogenesis of microcystin-LR toxicosis.

Cantor GH, Beckonert O, Bollard ME, Keun HC, Ebbels TM, Antti H, Wijsman JA, Bible RH, Breau AP, Cockerell GL, Holmes E, Lindon JC, Nicholson JK. Cantor GH, et al. Among authors: breau ap. Vet Pathol. 2013 Jan;50(1):159-71. doi: 10.1177/0300985812443839. Epub 2012 May 2. Vet Pathol. 2013. PMID: 22552484

2

Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.

Zhang JY, Zhan J, Cook CS, Ings RM, Breau AP. Zhang JY, et al. Among authors: breau ap. Drug Metab Dispos. 2003 May;31(5):652-8. doi: 10.1124/dmd.31.5.652. Drug Metab Dispos. 2003. PMID: 12695355

3

Metabonomic evaluation of idiosyncrasy-like liver injury in rats cotreated with ranitidine and lipopolysaccharide.

Maddox JF, Luyendyk JP, Cosma GN, Breau AP, Bible RH Jr, Harrigan GG, Goodacre R, Ganey PE, Cantor GH, Cockerell GL, Roth RA. Maddox JF, et al. Among authors: breau ap. Toxicol Appl Pharmacol. 2006 Apr 1;212(1):35-44. doi: 10.1016/j.taap.2005.06.021. Epub 2005 Jul 27. Toxicol Appl Pharmacol. 2006. PMID: 16051291

4

Pharmacokinetics and metabolism of a COX-2 inhibitor, valdecoxib, in mice.

Zhang JY, Yuan JJ, Wang YF, Bible RH Jr, Breau AP. Zhang JY, et al. Among authors: breau ap. Drug Metab Dispos. 2003 Apr;31(4):491-501. doi: 10.1124/dmd.31.4.491. Drug Metab Dispos. 2003. PMID: 12642477

5

A validated SPE-LC-MS/MS assay for Eplerenone and its hydrolyzed metabolite in human urine.

Zhang JY, Fast DM, Breau AP. Zhang JY, et al. Among authors: breau ap. J Pharm Biomed Anal. 2003 Feb 5;31(1):103-15. doi: 10.1016/s0731-7085(02)00595-2. J Pharm Biomed Anal. 2003. PMID: 12560054 Clinical Trial.

6

Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.

Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG, Laursen SM, Tymiak A, Car BD, Lehman-McKeeman L, Colet JM, Loukaci A, Thomas C. Lindon JC, et al. Among authors: breau ap. Toxicol Appl Pharmacol. 2003 Mar 15;187(3):137-46. doi: 10.1016/s0041-008x(02)00079-0. Toxicol Appl Pharmacol. 2003. PMID: 12662897

7

Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.

Zavisca FG, Breau AP, Wurtman RJ. Zavisca FG, et al. Among authors: breau ap. Circ Res. 1979 Nov;45(5):684-90. doi: 10.1161/01.res.45.5.684. Circ Res. 1979. PMID: 487531

8

Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.

Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM, Cogburn JN, Gresk CJ, Markos CS, Maziasz TJ, Schoenhard GL, Burton EG. Paulson SK, et al. Among authors: breau ap. Drug Metab Dispos. 2000 May;28(5):514-21. Drug Metab Dispos. 2000. PMID: 10772629

9

Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometry.

Zhang JY, Wang Y, Dudkowski C, Yang Dc, Chang M, Yuan J, Paulson SK, Breau AP. Zhang JY, et al. Among authors: breau ap. J Mass Spectrom. 2000 Nov;35(11):1259-70. doi: 10.1002/1096-9888(200011)35:11<1259::AID-JMS57>3.0.CO;2-9. J Mass Spectrom. 2000. PMID: 11114083

10

Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs.

Ahmad A, Ramakrishnan A, McLean MA, Li D, Rock MT, Karim A, Breau AP. Ahmad A, et al. Among authors: breau ap. Anal Biochem. 2002 Jan 15;300(2):177-84. doi: 10.1006/abio.2001.5467. Anal Biochem. 2002. PMID: 11779109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results